Chemical Structure : Lapatinib
CAS No.: 231277-92-2
货号: PC-45894Not For Human Use, Lab Use Only.
Lapatinib (GW572016) is a reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 mg (Free Sample) | ¥280 | In stock | |
100 mg | ¥780 | In stock | |
250 mg | ¥1280 | In stock | |
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Lapatinib (GW572016) is a reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.
Lapatinib (GW572016) displays no significant activity against other kinases, including ErbB4, c-Src, and c-Raf1.
Lapatinib (GW572016) reduces tyrosine phosphorylation of EGFR and erbB2, and inhibits activation of Erk1/2 and AKT both in vitro and in vivo.
Lapatinib (GW572016) inhibits tumor xenograft growth of the HN5 and BT474 cells in a dose-responsive manner at 30 and 100 mg/kg; orally active.
分子量 | 581.0576 | |
分子式 | C29H26ClFN4O4S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 39 mg/mL |
|
Chemical Name/SMILES |
4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]- |
1. Xia W, et al. Oncogene. 2002 Sep 12;21(41):6255-63.
2. Rusnak DW, et al. Mol Cancer Ther. 2001 Dec;1(2):85-94.
3. Konecny GE, et al. Cancer Res. 2006 Feb 1;66(3):1630-9.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright